as 12-17-2024 4:00pm EST
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Founded: | 2005 | Country: | United States |
Employees: | N/A | City: | N/A |
Market Cap: | 525.3M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 34.0K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | Monthly | |
EPS: | 1.44 | EPS Growth: | N/A |
52 Week Low/High: | $35.53 - $43.20 | Next Earning Date: | 01-01-0001 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
BME Breaking Stock News: Dive into BME Ticker-Specific Updates for Smart Investing
Business Wire
19 days ago
Business Wire
25 days ago
Business Wire
a month ago
Business Wire
a month ago
Business Wire
a month ago
Business Wire
a month ago
Business Wire
2 months ago
Business Wire
2 months ago
The information presented on this page, "BME Blackrock Health Sciences Trust - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.